5:15pm ET
Health and Healthcare
Why Citi Sees Huge Upside in 4 Top Biotechs Now
Citigroup came out with a biotech upgrade of sorts on Thursday. The firm issued brand new Buy ratings on four of the largest names within the biotech space.
Companies
/Healthcare
Biogen Inc
$218.50
▼ $3.00 (−1.35%) today
Markets closed · 11:18am ET
BIIB Coverage
Page 22
8:46am ET
Health and Healthcare
Short Interest Rises Across the Board in Major Biotechs
The February 12 short interest data have been compared with the previous report, and short interest increased across the board in these selected biotech stocks.
8:40am ET
Health and Healthcare
Major Biotech Short Interest Continues to Be Mixed
The January 29 short interest data have been compared with the previous report, and short interest was mixed in most of the selected biotech stocks.
9:50am ET
Health and Healthcare
The 4 Largest Biotech Stocks Are Cheaper Than S&P 500
A recent Jefferies research note indicates that the multiples for the four largest biotechs have dipped below that of the S&P for the first time since early in 2011, despite displaying higher…
10:10am ET
Health and Healthcare
Biotech Is the Cheapest Since 2011: 4 Top Stocks to Buy Now
Jefferies has four top biotech picks for 2016 that all have substantial upside and may provide investors with solid alpha for 2016.
8:35am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
Short interest increased in most of these selected biotech stocks for the most recent settlement date.
8:35am ET
Health and Healthcare
How Biogen Won at Earnings in Q4
Biogen reported better-than-expected fourth-quarter financial results before the markets opened on Wednesday.
Chris Lange 1:50pm ET
Health and Healthcare
What to Expect From Biogen Earnings
Biogen is set to report its fourth-quarter financial results before the markets open Wednesday.
Chris Lange 8:35am ET
Health and Healthcare
3 Top Jefferies Biotech Stocks to Buy for 2016 With Huge Upside Potential
These companies are well along in clinical trials and some are close to presenting Phase 3 results. Sticking with industry leaders always makes sense in a very volatile sector.
8:35am ET
Health and Healthcare
Short Interest Remains Mixed for Major Biotechs
The short interest data are out for the December 31 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More
The top analyst calls for Wednesday, January 6, 2016, include Bluebird Bio, Check Point Software, Comcast, Eli Lilly, Hyatt Hotels, Lockheed Martin and Rite Aid.
8:40am ET
Health and Healthcare
Short Interest Remains Mixed in Major Biotechs
The short interest data are out for the December 15 settlement date, and short interest continued to be mixed in these selected biotech stocks.
1:10pm ET
Economy
Apple, Google, Tesla Are World’s Most Innovative Companies
Over the past 10 years the single, most innovative company in the world has been Apple, according to the Boston Consulting Group.
8:40am ET
Health and Healthcare
Mixed Views on Major Biotech Short Interest
The November 30 short interest data have been compared with the previous report, and short interest was mixed in these selected stocks for this settlement date.
9:06am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
24/7 Wall St. has reviewed the short interest data on the top biotech companies.